Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-870-1 | CAS number: 7773-03-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Sensitisation data (human)
Administrative data
- Endpoint:
- sensitisation data (humans)
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Reliability:
- other: not rated acc. to Klimisch
- Rationale for reliability incl. deficiencies:
- other: Any kind of reliability rating is not considered to be applicable, since human studies/reports are not conducted/reported according to standardised guidelines.
Data source
Reference
- Reference Type:
- publication
- Title:
- Bronchospasm induced by metabisulphite-containing foods and drugs
- Author:
- Baker, G. J. et al.
- Year:
- 1 981
- Bibliographic source:
- The Medical Journal of Australia, 28: 614 - 617.
Materials and methods
- Type of sensitisation studied:
- respiratory
- Study type:
- case report
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Two case report about two typical cases of sulfite-provoked, life-threatening asthma. The two persons were challenge with sodium metabisulfite.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Disodium disulphite
- EC Number:
- 231-673-0
- EC Name:
- Disodium disulphite
- Cas Number:
- 7681-57-4
- Molecular formula:
- Na2S2O5
- IUPAC Name:
- disodium disulphite
- Test material form:
- not specified
- Details on test material:
- - Name of test material (as cited in study report): sodium metabisulfite
- Molecular formula: Na2S2O5
Constituent 1
Method
- Type of population:
- general
- Ethical approval:
- not specified
- Subjects:
- Case 1:
- Number of subjects exposed: 1 person
- Sex: female
- Age: 67-year-old
Case 2:
- Number of subjects exposed: 1 person
- Sex: female
- Age: 23- year-old - Clinical history:
- Case 1:
- Medical history: woman had a nine-year history of asthma which was well controlled by regular inhalations of salbutamol, beclomethasone and a small dose of orally administered betamethasone.
Case 2:
- Medical history: a nursing sister with a strong family history of asthma had suffered from atopic asthma since childhood. Many aeroallergens were known to precipitate her asthma, but wine was the only ingested substance she recognised as being asthma-provoking.
Until the age of 21 years, her asthma had been mild, managed with salbutamol and beclomethasone inhalers. She then experienced a two-year period of chronic, severe steroid-dependent asthma which necessitated multiple admissions to hospital. - Controls:
- no data
- Route of administration:
- oral
- Details on study design:
- Case 1:
TYPE AND DETAILS OF TEST(S) USED
The patient had eaten a tinned crabmeat salad to which a vinegar-based dressing was added. (Vinegar contains sodium metabisulfite.) Almost immediately, she had developed severe asthma.
In view of the severe asthmatic reaction closely related to ingestion of food, she was admitted to hospital two weeks later for oral challenge studies. She was challenged with tinned crabmeat from the same manufacturer and various food additives.
Case 2:
TYPE AND DETAILS OF TEST(S) USED
The woman came into the hospital with an asthma attack. Her asthma was assessed as moderately severe and therapy began with the following regimen: salbutamol every second hour, supplemented oxygen, intravenous injection of hydrocortisone and an infusion of 5% dextrose containing theophylline and dexamethasone over 12 hours.
For one hour after the infusion began, the patient's condition rapidly deteriorated, necessitating intubation and assisted ventilation. Twelve hours later, after extubation, the patient was essentially wheeze-free when given an intravenous injection of metoclopromide for nausea. Within minutes the patient developed acute bronchospasm. Inhaled salbutamol relieved the bronchospasm initially, then, over a period of one to two hours, airway obstruction had diminished. Review of her previous admission to hospital when intubation had been necessary demonstrated a similar pattern. That is, moderately severe asthma on arrival in hospital with rapid deterioration after theophylline and dexamethasone infusion began. (Metoclopramide, like the dexamethasone preparation administered, contains sodium metabisulfite, but not hydroxybenzoic acid.) At this stage sensitivity to metabisulfite was suspected.
A series of challenges was carried out while the patient was receiving an additive-free general-exclusion diet. Challenges were performed daily in a single blind fashion. The patient was given a capsule containing a test substance (for example 500 mg capsule sodium metabisulfite) or placebo each morning, then followed up serially with peak flow rate estimations for the next four to six hours. The patient was challenged with orally administered dexamethasone tablets which contain no preservatives.
Results and discussion
- Results of examinations:
- Case 1:
RESULT OF CASE REPORT: no reaction was observed after oral challenge with tinned crabmeat. Sodium metabisulfite produced severe bronchospams within 30 minutes of ingestion. No reaction was observed to the colouring agent tartrazine or to the preservative hydroxybenzoic acid.
Case 2:
RESULT OF CASE REPORT: Positive challenge reactions to sodium metabisulfite, sodium benzoate, and the colouring agent tartrazine were observed. The orally administered dexamethasone tablets which did not contain preservatives did not induce bronchospasm.
After challenged with sodium metabisulfite peak expiratory flow rate fell from 440 L/min to less than 200 L/min within 30 minutes of ingestion of the substance. Intravenous injections of theophylline and hydrocortisone, and inhaled salbutamol together with adrenaline (0.5 mL) were administered to relieve the severe bronchospasm.
Applicant's summary and conclusion
- Conclusions:
- Two women showed to be sensitive to sodium metabisulfite administered by food and/or pharmaceuticals.
No symptoms of an IgE-mediated reaction such as angioneurotic oedema, urticaria or rhinitis after an oral challenge with metabisulfite could be observed. Similar to previous studies the current study failed to demonstrate specific reaginic antobodies.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.